AI-powered · Expert-verified · China-based distributors
Singapore and Malaysia dossier support for China-based distributors
Support for China-based companies holding rights to sell overseas-manufactured medical devices, including diagnostics and IVDs, in Singapore and Malaysia.
Singapore and Malaysia professional fees from SGD 1,149.
Designed for
Cross-border dossier preparation
For China-based distributors and market-access teams with rights to sell German, European, US, or other overseas products. Everest Nova prepares documentation for client submission; regulator approval remains independent.
Where projects stall
The market-access problem is usually a documentation problem first.
The product may be manufactured in Europe while commercial rights sit with a China-based team.
Manufacturer documentation needs to be translated into a Singapore or Malaysia dossier workflow.
Time-zone and file-control issues slow down regulatory preparation.
What Everest Nova prepares
- Secure upload and messaging portal
- Manufacturer evidence gap list
- Country-specific documentation organization
- Final package ready for client submission
Scope and market
Everest Nova is Singapore-based, regional in focus, and built for cross-border documentation coordination with Everest Links Pte Ltd behind its medtech credibility.
A coordinated Singapore + Malaysia bundle and both eligible local-support options are available.
Next step
Start with a structured intake, not a messy email thread.
AI-assisted screening helps focus the first document requests; medtech experts verify the context, prepare the work, and control final delivery through the Everest Nova portal.
Everest Nova professional service fees are separate from government, regulatory authority, CAB, conformity-assessment, licensing, registration, and other third-party fees. Customers are responsible for paying those fees directly where applicable. Everest Nova prepares submission-ready regulatory dossiers. Direct submission to regulatory authorities is not included.
Everest Nova prepares documentation packages for client submission and does not guarantee regulatory approval. Approval outcomes depend on the product, evidence quality, data completeness, manufacturing controls, and the independent assessment of the relevant authority.
Also see Singapore regulator guide and Malaysia regulator guide.